Cite
HARVARD Citation
Bartscht, T. et al. (2015). Dasatinib blocks transcriptional and promigratory responses to transforming growth factor-beta in pancreatic adenocarcinoma cells through inhibition of Smad signalling: implications for in vivo mode of action. Molecular cancer. 14 (1), pp. 1-12. [Online].